Analyst Ranking
Bottom 7%
#4554 out of 4859 analysts
Average Return
-19.18%
Win Rate
18%12 out of 65
Risk vs Reward
Poor
Good

Leonid Timashev's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Newamsterdam Pharma Co NvNAMS
+164.57%$7.17$18.97
2023-10-30 -
2024-10-29
Buy
Edgewise Therapeutics IncEWTX
+131.48%$7.56$17.50
2023-06-28 -
2024-06-27
Buy
Axsome Therapeutics IncAXSM
+57.23%$82.11$129.10
2024-02-21 -
2025-02-20
Buy
Axsome Therapeutics IncAXSM
+56.88%$76.72$120.36
2024-03-26 -
2025-03-25
Buy
Pyxis Oncology IncPYXS
+56.70%$2.24$3.51
2023-09-05 -
2024-09-04
Buy

Leonid Timashev Analyst Color

Get additional color on Leonid Timashev's coverage of popular stocks

Leonid Timashev's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Edgewise Therapeutics IncEWTX
11Buy$52.00+299.08%Maintains
14 days ago
Pyxis Oncology IncPYXS
6Buy$8.00+756.53%Reiterates
a month ago
Brc IncBRCC
1Strong Buy$3.00+45.63%Maintains
a month ago
Insmed IncINSM
2Buy$100.00+42.45%Reiterates
a month ago
Alkermes PLCALKS
1Hold$40.00+47.06%Initiates Coverage On
a month ago
Biohaven LtdBHVN
10Buy$61.00+226.55%Reiterates
a month ago
Axsome Therapeutics IncAXSM
8Buy$192.00+83.78%Maintains
2 months ago
Newamsterdam Pharma Co NvNAMS
6Buy$40.00+149.53%Reiterates
3 months ago
Incyte CorpINCY
1Hold$70.00+21.25%Reiterates
3 months ago
Compass Pathways PLCCMPS
4Buy$18.00+502.01%Reiterates
3 months ago
Cytokinetics IncCYTK
2Buy$82.00+109.45%Maintains
4 months ago
Legend Biotech CorpLEGN
11Buy$86.00+157.02%Reiterates
4 months ago
Design Therapeutics IncDSGN
8Hold$4.00+18.34%Reiterates
8 months ago
Neubase Therapeutics IncNBSE
1Hold$20.00N/ADowngrades
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.